INTRODUCTION: Cutibacterium acnes is a recognized culprit for implant-associated infections, but positive cultures do not always indicate clinically relevant infection. Studies have shown a correlation between the β-hemolytic phenotype of C. acnes and its infectious capacity, but correlation with genetic phylotype has not been performed in literature. The purpose of this study is to evaluate β-hemolysis phenotype, genetic phylotype, and mid-term clinical outcomes of C. acnes isolated from orthopedic surgical sites. METHODS: Fifty-four C. acnes isolates previously obtained from surgical wounds of patients undergoing hip, knee, shoulder, or spine implant removal were re-cultured. There were 21 females and 33 males with an average age of 59 years (range, 18-84). Twenty-four were from clinically infected sites whereas 30 were considered contaminants. De novo β-hemolysis was analyzed and a retrospective chart review was performed to evaluate clinical outcomes at 7.1 years (range, 0.1-12.8). RESULTS: On Brucella agar with 5% rabbit blood, 46% of contaminant and 43% of infectious isolates were hemolytic. Type II phylotype was significantly more nonhemolytic regardless of infectious or contaminant status (p < 0.05). Type 1B correlated with a hemolytic-infectious phenotype and Type 1A with a hemolytic-contaminant phenotype but was not statistically significant. CONCLUSION: The β-hemolytic profile of C. acnes did not correlate with phylotype or clinically relevant orthopedic infection.
INTRODUCTION: Cutibacterium acnes is a recognized culprit for implant-associated infections, but positive cultures do not always indicate clinically relevant infection. Studies have shown a correlation between the β-hemolytic phenotype of C. acnes and its infectious capacity, but correlation with genetic phylotype has not been performed in literature. The purpose of this study is to evaluate β-hemolysis phenotype, genetic phylotype, and mid-term clinical outcomes of C. acnes isolated from orthopedic surgical sites. METHODS: Fifty-four C. acnes isolates previously obtained from surgical wounds of patients undergoing hip, knee, shoulder, or spine implant removal were re-cultured. There were 21 females and 33 males with an average age of 59 years (range, 18-84). Twenty-four were from clinically infected sites whereas 30 were considered contaminants. De novo β-hemolysis was analyzed and a retrospective chart review was performed to evaluate clinical outcomes at 7.1 years (range, 0.1-12.8). RESULTS: On Brucella agar with 5% rabbit blood, 46% of contaminant and 43% of infectious isolates were hemolytic. Type II phylotype was significantly more nonhemolytic regardless of infectious or contaminant status (p < 0.05). Type 1B correlated with a hemolytic-infectious phenotype and Type 1A with a hemolytic-contaminant phenotype but was not statistically significant. CONCLUSION: The β-hemolytic profile of C. acnes did not correlate with phylotype or clinically relevant orthopedic infection.
Authors: Andrej Trampuz; Kerryl E Piper; Melissa J Jacobson; Arlen D Hanssen; Krishnan K Unni; Douglas R Osmon; Jayawant N Mandrekar; Franklin R Cockerill; James M Steckelberg; James F Greenleaf; Robin Patel Journal: N Engl J Med Date: 2007-08-16 Impact factor: 91.245
Authors: Jasvinder A Singh; John W Sperling; Cathy Schleck; William Harmsen; Robert H Cofield Journal: J Shoulder Elbow Surg Date: 2011-12-11 Impact factor: 3.019
Authors: Travis M Falconer; Mohammed Baba; Lisa M Kruse; Oscar Dorrestijn; Matthew J Donaldson; Margaret M Smith; Melanie C Figtree; Bernard J Hudson; Benjamin Cass; Allan A Young Journal: J Bone Joint Surg Am Date: 2016-10-19 Impact factor: 5.284
Authors: Jared M Mahylis; Vahid Entezari; James Karichu; Sandra Richter; Kathleen A Derwin; Joseph P Iannotti; Eric T Ricchetti Journal: J Shoulder Elbow Surg Date: 2018-02-19 Impact factor: 3.019
Authors: Rolf L W Petersen; Christian F P Scholz; Anders Jensen; Holger Brüggemann; Hans B Lomholt Journal: Eur J Microbiol Immunol (Bp) Date: 2017-02-27